Randomized phase III study of TS-1 [S-1] alone versus TS-1 plus lentinan(LNT) in advanced or recurrent gastric cancer (ACG)
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Lentinan (Primary) ; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Therapeutic Use
- 16 Jan 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 22 Jan 2007 New trial record.